• Publications
  • Influence
Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry.
The genesis of Tourette syndrome is still unknown, but a core role for the pathways of cortico-striatal-thalamic-cortical circuitry (CSTC) is supposed. Volume-rendering magnetic resonance imagingExpand
  • 69
  • 8
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Background and purpose:  There is increasing evidence that not only the monoaminergic but also the glutamatergic system is involved in the pathophysiology of attention‐deficit hyperactivity disorderExpand
  • 64
  • 7
European clinical guidelines for Tourette Syndrome and other tic disorders. Part I: assessment
A working group of the European Society for the Study of Tourette Syndrome (ESSTS) has developed the first European assessment guidelines of Tourette Syndrome (TS). The available literature includingExpand
  • 129
  • 6
Prone to excitement: Adolescent females with non-suicidal self-injury (NSSI) show altered cortical pattern to emotional and NSS-related material
Emotion-regulation difficulties have been identified as one of the core components in Non-suicidal self-injury (NSSI), a behaviour often beginning in adolescence. This pilot study evaluatedExpand
  • 48
  • 5
Neurodevelopmental and neurodegenerative diseases - is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples.
Attention-deficit/hyperactivity disorder (ADHD), the most common neurobehavioural disorder and amyotrophic lateral sclerosis (ALS), the most common adult motoneuron disease, may be two distinctExpand
  • 15
  • 3
‘‘Stop Cutting—Rock!’’: A Pilot Study of a Music Therapeutic Program for Self-Injuring Adolescents
Abstract Music and Medicine 2(1) 59-65 a The Author(s) 2010 Reprints and permission: http://www. sagepub.com/journalsPermissions.nav DOI: 10.1177/1943862109356928 http://mmd.sagepub.com NonsuicidalExpand
  • 30
  • 3
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
To develop a European guideline on pharmacologic treatment of Tourette syndrome (TS) the available literature was thoroughly screened and extensively discussed by a working group of the EuropeanExpand
  • 58
  • 2
Therapeutic drug monitoring of children and adolescents treated with fluoxetine.
INTRODUCTION Information about therapeutic serum levels of fluoxetine (FLX) and its major metabolite norfluoxetine (NORFLX) in children and adolescents is scarce. METHODS Therapeutic drugExpand
  • 18
  • 2
Pre- and perinatal complications in relation to Tourette syndrome and co-occurring obsessive-compulsive disorder and attention-deficit/hyperactivity disorder.
Pre- and perinatal complications have been implicated in the onset and clinical expression of Tourette syndrome albeit with considerable inconsistencies across studies. Also, little is known aboutExpand
  • 16
  • 2
Tourette syndrome and other tic disorders in childhood, adolescence and adulthood.
BACKGROUND Tourette syndrome is a combined motor and vocal tic disorder that begins in childhood and takes a chronic course. It arises in about 1% of all children, with highly varying severity.Expand
  • 27
  • 2